108 related articles for article (PubMed ID: 15219826)
1. Analysis of tamoxifen-DNA adducts in endometrial explants by MS and 32P-postlabeling.
Beland FA; Churchwell MI; Hewer A; Phillips DH; Gamboa da Costa G; Marques MM
Biochem Biophys Res Commun; 2004 Jul; 320(2):297-302. PubMed ID: 15219826
[TBL] [Abstract][Full Text] [Related]
2. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.
Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM
J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972
[TBL] [Abstract][Full Text] [Related]
3. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
[TBL] [Abstract][Full Text] [Related]
4. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC
Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927
[TBL] [Abstract][Full Text] [Related]
5. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
[TBL] [Abstract][Full Text] [Related]
6. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
[TBL] [Abstract][Full Text] [Related]
7. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen.
Shibutani S; Ravindernath A; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML
Carcinogenesis; 2000 Aug; 21(8):1461-7. PubMed ID: 10910945
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen.
Shibutani S; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML
Chem Res Toxicol; 1999 Jul; 12(7):646-53. PubMed ID: 10409405
[TBL] [Abstract][Full Text] [Related]
10. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC
Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611
[TBL] [Abstract][Full Text] [Related]
11. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.
Hemminki K; Rajaniemi H; Lindahl B; Moberger B
Cancer Res; 1996 Oct; 56(19):4374-7. PubMed ID: 8813128
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of pyrrolizidine alkaloid-derived DNA adducts in vitro and in vivo.
Fu PP; Chou MW; Churchwell M; Wang Y; Zhao Y; Xia Q; Gamboa da Costa G; Marques MM; Beland FA; Doerge DR
Chem Res Toxicol; 2010 Mar; 23(3):637-52. PubMed ID: 20078085
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tamoxifen-DNA adducts by high-performance liquid chromatography using postcolumn online photochemical activation.
Sharma M
Biochem Biophys Res Commun; 2000 Jun; 273(1):40-4. PubMed ID: 10873560
[TBL] [Abstract][Full Text] [Related]
15. Detection of in vivo formed DNA adducts at the part-per-billion level by capillary liquid chromatography/microelectrospray mass spectrometry.
Gangl ET; Turesky RJ; Vouros P
Anal Chem; 2001 Jun; 73(11):2397-404. PubMed ID: 11403278
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
17. Lack of genotoxicity of tamoxifen in human endometrium.
Carmichael PL; Ugwumadu AH; Neven P; Hewer AJ; Poon GK; Phillips DH
Cancer Res; 1996 Apr; 56(7):1475-9. PubMed ID: 8603387
[TBL] [Abstract][Full Text] [Related]
18. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
Shibutani S; Kim SY; Suzuki N
Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometrium.
Carmichael PL; Sardar S; Crooks N; Neven P; Van Hoof I; Ugwumadu A; Bourne T; Tomas E; Hellberg P; Hewer AJ; Phillips DH
Carcinogenesis; 1999 Feb; 20(2):339-42. PubMed ID: 10069474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
